Loading clinical trials...
Loading clinical trials...
Open-label Clinical Investigation to Evaluate the Safety and Efficacy of Glucosanol in Maintaining Body Weight Loss in Overweight and Obese Subjects
Conditions
Interventions
Glucosanol
Locations
1
Germany
Barbara Grube, MD
Berlin, Germany
Start Date
September 1, 2011
Primary Completion Date
May 1, 2012
Completion Date
July 1, 2012
Last Updated
July 27, 2012
NCT01143454
NCT07472881
NCT07010757
NCT06223555
NCT06989203
NCT07237750
Lead Sponsor
InQpharm Group
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions